Vaxil Bio Ltd.
VXL.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 396.00K | 430.40K | 679.40K | 710.30K | 745.90K |
| Total Receivables | 211.00K | 200.20K | 9.60K | 14.40K | 30.30K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | 14.40K | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 607.00K | 630.50K | 689.00K | 739.00K | 776.20K |
|
|
|||||
| Total Current Assets | 607.00K | 630.50K | 689.00K | 739.00K | 776.20K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 607.00K | 630.50K | 689.00K | 739.00K | 776.20K |
|
|
|||||
| Total Accounts Payable | 60.70K | 50.40K | 67.20K | 60.60K | 140.50K |
| Total Accrued Expenses | -- | 5.10K | 5.20K | 3.80K | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 60.70K | 55.50K | 72.40K | 64.40K | 140.50K |
|
|
|||||
| Total Current Liabilities | 60.70K | 55.50K | 72.40K | 64.40K | 140.50K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 60.70K | 55.50K | 72.40K | 64.40K | 140.50K |
|
|
|||||
| Common Stock & APIC | 11.90M | 11.74M | 11.87M | 12.17M | 11.88M |
| Retained Earnings | -14.44M | -14.22M | -14.34M | -14.66M | -14.33M |
| Treasury Stock & Other | 3.09M | 3.05M | 3.08M | 3.16M | 3.08M |
| Total Common Equity | 546.30K | 575.00K | 616.60K | 674.70K | 635.70K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 546.30K | 575.00K | 616.60K | 674.70K | 635.70K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 546.30K | 575.00K | 616.60K | 674.70K | 635.70K |
|
|
|||||
